Jiangxi Institute of Biological Products Inc. (HKG:6915)

HKG:6915 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.00	0.00	0.00	0.06
Debt / EBITDA Ratio	0.01	0.01	0.01	0.35
Debt / FCF Ratio	0.04	0.04	0.01	0.55
Net Debt / Equity Ratio	-0.15	-0.15	-0.14	-0.10
Net Debt / EBITDA Ratio	-0.65	-0.65	-0.60	-0.63
Net Debt / FCF Ratio	-3.52	-3.52	-0.65	-0.97
Asset Turnover	0.45	0.45	0.45	-
Inventory Turnover	0.90	0.90	1.15	-
Quick Ratio	2.95	2.95	1.52	0.96
Current Ratio	4.20	4.20	2.30	1.39
Return on Equity (ROE)	21.04%	21.04%	19.64%	-
Return on Assets (ROA)	12.08%	12.08%	10.42%	-
Return on Invested Capital (ROIC)	22.78%	22.78%	20.12%	12.91%
Return on Capital Employed (ROCE)	20.30%	20.30%	20.40%	13.20%
Payout Ratio	-	-	54.32%	155.30%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 16, 2026

Data Sources Report a data error